PRF vs PRP Centrifugation and Anticoagulant Protocols
How do the centrifugation protocols and use of anticoagulants differ between PRF and PRP?
The split between these two preparations happens before the centrifuge lid ever closes, in the tube you choose to draw into. Add citrate and you've bought yourself hours of working time plus the option to spin hard twice; leave the tube plain and the clock starts at about sixty seconds and you get a fibrin scaffold instead of a liquid. Knowing which one you're holding tells you almost everything else about how that sample is going to behave.
| Protocol Element | PRP | PRF |
|---|---|---|
| Tube additive | ACD-A or 3.2% buffered sodium citrate | None, plain glass or silica coated |
| Spin force | 100 to 300 g soft, then 1000 to 1500 g | 400 g classic, 60 to 200 g advanced |
| Number of spins | One or two | One only |
| Draw to rotor window | Hours | 60 to 90 seconds |
| Final product | Liquid concentrate, 3 to 7x baseline | Fibrin clot releasing over 7 to 10 days |
PRP is drawn into a citrate anticoagulant and spun at 100 to 1500 g to yield a liquid concentrate three to seven times baseline, while PRF is drawn additive free into glass, spun once at roughly 60 to 400 g within ninety seconds, and sets into a fibrin scaffold that releases growth factors over seven to ten days.
What relative centrifugal force and spin duration define a typical PRP preparation protocol?
The number on the dial is the one you should trust least. Rpm only means something once you know the rotor radius, so two clinics both running 3200 rpm can hand their patients visibly different products, and it's g force that lets you line your protocol up against anyone else's.
A competent PRP protocol recovers 70 to 80 percent of the platelets in the original draw, using 200 to 300 g for eight to ten minutes in a single spin or a 100 to 200 g soft spin followed by 1000 to 1500 g for five to fifteen minutes.
What makes the low speed centrifugation concept central to platelet rich fibrin preparation?
Spin a clot hard and you'll pack most of the useful cells into the bottom few millimetres, right up against the red layer you're about to trim off and bin. Ease the force back and those same cells spread up through the body of the membrane, which is the part you'll actually place. That one adjustment changes both what's in the scaffold and how it behaves once it's sitting in the tissue.
- Cell distribution: Lower force spreads leukocytes and platelets through the fibrin body, not the discarded base.
- Fibrin architecture: Slow polymerisation builds a wide pore equilateral mesh instead of a tight bilateral network.
- Release profile: Porous matrix releases growth factors steadily across seven to ten days, not one burst.
- The floor: Below the useful band separation fails and red cells stay dispersed in the clot.
Advanced fibrin protocols run at roughly 200 g for eight minutes and injectable versions at 60 to 100 g for three minutes, well below the classic 400 g for twelve minutes, because lower force spreads platelets and leukocytes through the usable body of the clot.
Why does PRP require an anticoagulant while PRF is drawn and spun without one?
Left alone, a venous sample is visibly clotting inside five to ten minutes and firmly set by twenty. Citrate binds the ionised calcium the cascade depends on and parks the reaction at the starting line, which is the only reason you can pipette, re-spin and resuspend a PRP sample at all. PRF makes the opposite bet: the gel isn't a problem to be prevented, it's the thing you came to collect.
Citrate anticoagulants keep a PRP sample fluid for hours by chelating the ionised calcium the clotting cascade needs, while an additive free PRF tube must reach the rotor within sixty to ninety seconds because fibrin polymerises during the spin itself.
Which anticoagulants are used in platelet concentrate preparation and how do they differ in effect?
Three additives come up in this conversation and only two of them belong anywhere near a platelet concentrate. The ranking isn't about how well each one stops the clotting, since they all manage that; it's about what they do to your platelets while they're holding the cascade off. Heparin sits outside the list entirely, because it works on antithrombin instead of calcium and behaves as a platelet agonist that clumps cells in the tube.
Acid citrate dextrose solution A and 3.2 percent buffered sodium citrate are the two acceptable anticoagulants for platelet concentrates at a ratio near one part additive to nine parts blood, while EDTA damages platelet membranes and heparin acts as a platelet agonist.
How does the collection tube itself, its material and its coating, change the outcome of a spin?
When you add nothing to the blood, the tube stops being a container and starts working as a reagent. Glass fires factor XII on contact and starts the intrinsic pathway straight away, which is why plain polypropylene hands you a slow, poorly formed clot or no usable membrane at all.
- Glass tubes: Negatively charged hydrophilic surface triggers contact activation immediately, the original fibrin standard.
- Silica coated plastic: Restores fast activation and resists breakage, but particles can shed into an injectable.
- Separator gel: Sits at the density boundary the platelet layer wants, trapping part of your harvest.
- Tube geometry and fill: Path length and fill height shift the boundary, so the fill line is protocol.
Glass and silica coated tubes drive the contact activation that additive free fibrin protocols depend on, and because silica particles can shed into a liquid preparation, injectable products call for genuine glass or certified silica free tubes.
What does a single spin protocol capture compared with a double spin protocol?
The second spin isn't there to collect more platelets. It removes water, so the same population you already had ends up sitting in a smaller volume, and every transfer and resuspension along the way costs you some of it. Judge a protocol on recovery as well as concentration factor, or you'll be impressed by a kit that simply threw away more plasma.
| Criteria | Single Spin | Double Spin |
|---|---|---|
| Concentration factor | 1.5 to 3x baseline | 4 to 7x baseline |
| Platelet recovery | Higher, fewer handling losses | Lower, losses at each transfer |
| Red cell carryover | Very low | Low, depends on interface technique |
| Reproducibility between staff | High, less operator dependent | Lower, more chance of premature activation |
A single spin yields one and a half to three times baseline with fewer handling losses, while a second spin at high force removes plasma to reach four to seven times baseline without harvesting a single additional platelet.
How does the time between venipuncture and centrifugation affect the final product?
For an additive free draw the clock starts at the needle, and it won't wait while you finish setting up. Get the rotor spinning inside about sixty seconds, treat ninety as the outer limit, and keep the centrifuge in the room with the patient rather than down the corridor.
- Draw clean: Use an adequate gauge, short tourniquet time and gentle aspiration; probing releases tissue factor.
- Cap and move: Tubes go into the rotor in the order they were drawn, inside sixty seconds.
- Balance and start: Run what you have rather than holding early tubes while the last ones fill.
- Split large sets: Two batches with two spins beat one batch where the first tube sat waiting.
An additive free draw must reach the centrifuge within roughly sixty seconds and no later than ninety, because a sample left standing sets its fibrin around gravity settled cells and yields a smaller, denser membrane holding fewer platelets.
What goes wrong when the spin parameters or the blood handling drift from protocol?
The failure that costs most clinics a tube isn't carelessness, it's the assumption that rpm travels between machines. Different rotor radii and different angles of repose deliver different g forces at the same dial setting, so a protocol borrowed from a paper can be hundreds of g out while everything looks perfectly normal. Read the tube before you draw from it, because it will tell you what actually happened.
Identical rpm on two centrifuges produces different g forces because relative centrifugal force depends on rotor radius, and over concentration carries its own risk, since very high platelet concentrations have been associated with inhibitory rather than stimulatory effects on cell proliferation.
How do regulatory and minimal manipulation rules shape which protocols a clinic can use?
Autologous platelet preparations have generally been treated as a procedure rather than a manufactured drug, and that standing rests on two conditions you have to keep meeting. The material stays minimally manipulated, and it's used for a homologous purpose in the same person during the same procedure. Step outside either one and you've moved your product into a far heavier category.
- Minimal manipulation: Centrifugation and simple separation don't alter the relevant biological characteristics of the cells.
- Accepted processing aids: Citrate to prevent clotting and calcium chloride to trigger it stay inside the boundary.
- Device clearance: Kits carry class II clearance for one defined protocol; off spec settings leave it.
- Documentation: Record tube type, additive and volume, g force rather than rpm, duration and volume delivered.
Autologous platelet preparations keep their minimal manipulation standing only when centrifugation and simple separation are the extent of the processing, the product is used for a homologous purpose in the same person during the same procedure, and the kit is run inside the protocol its class II clearance covers.
